Skip to main content
SpringerLink
Log in

NAFLD and NASH

Biomarkers in Detection, Diagnosis and Monitoring

  • Book
  • © 2020

Overview

Editors:
  1. Manuel Romero-Gomez

    1. UCM Digestive Diseases, Virgen del Rocio University Hospital, Sevilla, Spain

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Presents most up-to-date information on hepatic biomarkers

  • Discusses the key methods to detecting Non Alcoholic Steatohepatitis

  • Reviews both biochemical and imaging biomarkers

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (13 chapters)

  1. Front Matter

    Pages i-x
    Download chapter PDF

  2. The Spectrum of NAFLD: From the Organ to the System

    • Yolanda Sanchez-Torrijos, Javier Ampuero
    Pages 1-10

  3. Detection of NAFLD/NASH in the General Population and in Primary Care Clinics

    • Maya Margalit, Hanny Yeshua, Neta Gotlieb, Shira Zelber-Sagi
    Pages 11-27

  4. Genes and NAFLD/NASH Progression

    • Rasha El Sharkawy, Jacob George, Mohammed Eslam
    Pages 29-47

  5. Geometry of Nutrition: Nutrients and NAFLD Progression

    • Genoveva Berná, Leticia Álvarez-Amor, Franz Martín
    Pages 49-67

  6. Biomarkers in Pediatric NAFLD

    • María Rubio-Murillo, Alejandro Rodríguez-Martínez
    Pages 69-88

  7. Biochemical Biomarkers of NAFLD/NASH

    • Ciro Celsa, Grazia Pennisi, Federica Spatola, Aurora Giannetti, Salvatore Petta
    Pages 89-114

  8. Non-invasive Assessment of Non-alcoholic Fatty Liver Disease: Ultrasound and Transient Elastography

    • Tao Wan, Annalisa Berzigotti
    Pages 115-139

  9. MR Based-Imaging Biomarkers in NAFLD/NASH

    • Michael Pavlides
    Pages 141-156

  10. Extracellular Vesicles in Non-alcoholic Fatty Liver Disease: Key Players in Disease Pathogenesis and Promising Biomarker Tools

    • Pedro M. Rodrigues, Ainhoa Lapitz, André L. Simão, Maria J. Perugorria, Marco Arrese, Rui E. Castro et al.
    Pages 157-180

  11. From Transcriptomic to Metabolomic in the Development of Biomarkers in NAFLD/NASH

    • George V. Dedoussis, Athina I. Amanatidou
    Pages 181-190

  12. HCC in Patients with NAFLD/NASH

    • Jose Tadeu Stefano, Fernanda de Mello Malta, Priscila Brizola de Campos, Pedro Fernandes Andrade, Denise Cerqueira Paranaguá-Vezzozo, Flair Jose Carrilho et al.
    Pages 191-203

  13. Psychological Biomarker Profile in NAFLD/NASH with Advanced Fibrosis

    • Jesús Funuyet-Salas, Agustín Martín-Rodríguez, Rupert Conrad, María Ángeles Pérez-San-Gregorio
    Pages 205-223

  14. Integrative Proposal for the Use of Biomarkers in Clinical Practice Management of NAFLD/NASH

    • Carlos Benítez, Juan Pablo Arab, Francisco Barrera, Jesus M. Banales, Marco Arrese
    Pages 225-236
Back to top

Keywords

About this book

This book provides a comprehensive overview of the diagnosis and management of Non-alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatis (NASH). Basic principles of disease progression, the genetic and nutritional basis of NAFLD and NASH are explained along with the proteomic principles underlying biomarker development. Chapters cover both biochemical and imaging biomarkers used in elastrography and ultrasound and discuss how these are applicable to early diagnosis and monitoring of NASH and NAFLD.  

This is a useful resource for hepatologists, primary care providers with an interest in metabolic disease, diabetologists and endocrinologists in their daily clinical practice.


Editors and Affiliations

  • UCM Digestive Diseases, Virgen del Rocio University Hospital, Sevilla, Spain

    Manuel Romero-Gomez

About the editor

MANUEL ROMERO GÓMEZ Is Full-Professor of Medicine in the University of Seville, Spain. Digestive Diseases Department at Virgen del Rocío University Hospitals. Institute of Biomedicine of Seville (IBIS). University of Seville. Spain.

Coordinator of the Spanish Registry of NAFLD/NASH (HepaMET) and co-coordinator of the EASL supported European Registry of NAFLD. Principal Investigator of the group for research in the Spanish Network for Research in Digestive and liver diseases (CiberEHD).

 Prof Romero-Gómez received the XI Award Javier Benjumea Puigcerver in investigation, Universidad de Sevilla-Focus Abengoa, 2014. He was awarded with the Medal of The City of Seville in 2016. He has published more than 300 peer-reviewed papers on gastrointestinal and liver diseases. He has protected 10 patents and participated as PI in more than 20 competitive grants for research.

Bibliographic Information

  • Book Title: NAFLD and NASH

  • Book Subtitle: Biomarkers in Detection, Diagnosis and Monitoring

  • Editors: Manuel Romero-Gomez

  • DOI: https://doi.org/10.1007/978-3-030-37173-9

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Nature Switzerland AG 2020

  • Hardcover ISBN: 978-3-030-37172-2Published: 29 February 2020

  • Softcover ISBN: 978-3-030-37175-3Published: 28 February 2021

  • eBook ISBN: 978-3-030-37173-9Published: 28 February 2020

  • Edition Number: 1

  • Number of Pages: X, 236

  • Number of Illustrations: 1 b/w illustrations, 17 illustrations in colour

  • Topics: Hepatology, Endocrinology, Metabolomics

Publish with us

Policies and ethics

Back to top

Search

Navigation